Variation in Vasoactive Treatment Selection for Cardiogenic Shock: Insights From the Critical Care Cardiology Trials Network (CCCTN)

By afschroeder • May 7, 2026

Hamilton DE, Shriver JL, Patel SM, Park JG, Michos ZE, Mathis MR, Adie SK, Alviar CL, Barnett CF, Berg DD, Bennett CE, Bohula EA, Carnicelli AP, Daniels LB, Dodson MW, Gage A, Gidwani U, Goldfarb M, Katz JN, Ketcham SW, Kwon Y, Leibner ES, Loriaux DB, Luk A, Marano P, Miller PE, Mukundan SV, Papolos AI, Pisani BA, Proudfoot AG, Roswell RO, Shah KS, Solomon MA, Tomey MI, van Diepen S, Zakaria S, Morrow DA, Thompson AD; CCCTN Investigators. Variation in Vasoactive Treatment Selection for Cardiogenic Shock: Insights From the Critical Care Cardiology Trials Network (CCCTN). Circ Heart Fail. 2026 May 7:e013778. doi: 10.1161/CIRCHEARTFAILURE.125.013778. Epub ahead of print. PMID: 42093634.

Tags: angiography, Cardiology/Epi, Cedars Sinai DoM, critical care, heart failure, humans, odds ratio, Publications

Outcome of Patients Presenting With High-Risk Pulmonary Embolism Treated With Mechanical Thrombectomy: A Subgroup Analysis From the STRIKE-PE Study

Sharp ASP, Dohad SY, Weinberg I, Kurzyna M, Davis HC, Stepniewski J, Perkowski PE, Holden A, West FM, Keeling WB, Parikh SA, Moriarty JM. Outcome[...]

Glucagon-Like Peptide 1 Receptor Agonists are Associated With Reduced Risk of Hepatic Encephalopathy in Cirrhosis

Singh V, Wang M, Ebinger J, Velazquez A, Cheng S, Kwan AC, Trivedi HD. Glucagon-Like Peptide 1 Receptor Agonists are Associated With Reduced Risk of[...]

Temporal Trends and Future Projections of Pulmonary Embolism and Top Contributing Causes of death in the United States, 1968-2040: insights from the CDC WONDER database

Khan S, Abbas F, Hassan M, Hussain M, Ahmed M, Ahsan A, Qureshi S, Khalid N, Sajjad A, Baig M, Waqas SA, Fonarow GC, Greene[...]